Schonfeld Strategic Advisors LLC

Position in OCGN — Ocugen, Inc.

CIK 1665241 NEW YORK, NY

Position in OCGN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$196,683

+$158,983 QoQ

Shares Held

108,665

+289.1% QoQ

Ownership

0.032%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Schonfeld Strategic Advisors LLC holds $243,253,028 across 126 Biotechnology names. OCGN ranks #72 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	71,767	$23,745,547
2	PTCT	Ptc Therapeutics, Inc.	318,405	$21,692,932
3	XENE	Xenon Pharmaceuticals Inc.	324,722	$18,882,584
4	INBX	Inhibrx Biosciences, Inc.	254,827	$17,132,019
5	JAZZ	Jazz Pharmaceuticals plc	62,142	$11,747,945
6	RARE	Ultragenyx Pharmaceutical Inc.	494,737	$10,364,740
7	INSM	INSMED Inc	56,056	$9,166,277
8	ELVN	Enliven Therapeutics, Inc.	218,867	$8,579,586

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$196,683	108,665	+289.1%	Shares	Sole	2026-05-15
2025-12-31	$37,700	27,926	-49.8%	Shares	Sole	2026-02-17
2025-06-30	$53,951	55,620	-4.6%	Shares	Sole	2025-08-14
2023-06-30	$31,656	58,300	-41.0%	Shares	Sole	2023-08-14
2022-12-31	$128,440	98,800	-74.1%	Shares	Sole	2023-02-14
2022-09-30	$679,586	381,790	+883.4%	Shares	Sole	2022-11-14
2022-06-30	$88,125	38,822	+5.5%	Shares	Sole	2022-08-15
2022-03-31	$121,440	36,800	-15.2%	Shares	Sole	2022-05-16
2021-12-31	$197,470	43,400	-16.2%	Shares	Sole	2022-02-14
2021-09-30	$371,924	51,800	+78.0%	Shares	Sole	2021-11-16
2021-06-30	$233,673	29,100	—	Shares	Sole	2021-11-16
No filing history on record for this holder in this stock.